{
  "folder": "IC-267",
  "content": "{{knowledge objective\n|Identifiant=OIC-267-17-A\n|Item_parent=Disorders of acid-base balance and fluid-electrolyte disorders\n|Item_parent_short=Disorders of acid-base equilibrium and fluid and electrolyte disorders\n|Rank=A\n|Title=Knowing the treatment of moderate chronic hyperkalaemia\n|Description=Dietetics, exchange resins, avoidance of high-risk drugs\n|Section=Management\n|Contributors=P Rieu; B Moulin; M Flamant\n|Order=17}}\n\n\n*reducing dietary and intravenous potassium intake;\n*adjustment of the dosage of hyperkalaemic drugs;\n*correction of moderate metabolic acidosis (oral sodium bicarbonate 2-4 g/d);\n*administration of ion exchange resins (sodium polystyrene sulphonate, KAYEXALATE\u00ae) may supplement treatment.\n*administration of hypokalaemic diuretics (loop or thiazide diuretics) in the event of hypertension or fluid overload.\n*Hyperkalaemia with hypoaldosteronism (adrenal insufficiency) is effectively treated with 9\u03b1-fluorohydrocortisone.",
  "question": {
    "properties": {
      "question": "What is the primary treatment for moderate chronic hyperkalaemia?",
      "option_a": "Reducing dietary and intravenous potassium intake;",
      "option_b": "Adjustment of the dosage of hyperkalaemic drugs;",
      "option_c": "Correction of moderate metabolic acidosis (oral sodium bicarbonate 2-4 g/d);",
      "option_d": "Administration of ion exchange resins (sodium polystyrene sulphonate, KAYEXALATE\u00ae) may supplement treatment.",
      "correct_option": "option_d"
    },
    "required": [
      "question",
      "correct_option"
    ],
    "required_items": [
      "question",
      "correct_option"
    ]
  }
}